Quantcast

Posts related to ‘NCST’

52-Week High Club (NCST, SMD)

NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST) rose over 70% to a yearly high of $1.70.  Its rise was driven by the news that Smith & Nephew Plc (NYSE: SNN) has agreed ...
Read Full Story »

Biotech Busine$$ Daily (BNT, TEVA, BPAX, NCST, RPRX, VRTX)

Bentley Pharmaceuticals Inc. (NYSE: BNT) will be purchased by Teva Pharmaceutical Industries (NASDAQ: TEVA) for $360 million. Bentley shareholders will receive $15 per share and an undisclosed amount of shares ...
Read Full Story »

Nucryst Pharmaceuticals (NCST) Rallies Like A House On Fire

Nucryst Pharmaceuticals (NCST) is up over 100% to $4.40 on news that the FDZ cleared its antimicrobial cream containing the compound NPI 32101  Of course, there was no revenue forecast ...
Read Full Story »